Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Diagn Microbiol Infect Dis

Retrieve available abstracts of 106 articles:
HTML format



Single Articles


    December 2022
  1. TSUNEOKA H, Otsuyama KI, Hirano A, Nojima J, et al
    Clinical utility of indirect fluorescent assay for IgA class antibodies against Bartonella henselae in serodiagnosis of cat scratch disease in its early stage.
    Diagn Microbiol Infect Dis. 2022;104:115809.
    PubMed     Abstract available


  2. SANCHEZ NO, Perez NF, Martinez SB
    Evaluation of the viasure Neisseria gonorrhoeae ciprofloxacin resistant assay for the simultaneous identification and direct detection of ciprofloxacin susceptibility.
    Diagn Microbiol Infect Dis. 2022;104:115798.
    PubMed     Abstract available


  3. HUANG HY, Chang YT, Lu PL, Yang TY, et al
    Correlation of Vitek 2 and Agar dilution for levofloxacin susceptibility testing and clinical outcomes of Enterobacterales bacteremia with 2019 CLSI breakpoints.
    Diagn Microbiol Infect Dis. 2022;104:115799.
    PubMed     Abstract available


  4. PFALLER M, Mendes RE, Streit JM, Carvalhaes CG, et al
    Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA, Europe, Latin America, and the Asia-Pacific region (2015-2019).
    Diagn Microbiol Infect Dis. 2022;104:115804.
    PubMed     Abstract available


  5. GARCIA-RIVERA C, Parra-Grande M, Merino E, Boix V, et al
    Concordance of the filmarray blood culture identification panel 2 and classical microbiological methods in a bacteriemia diagnostic unit.
    Diagn Microbiol Infect Dis. 2022;104:115787.
    PubMed     Abstract available


  6. XIA D, Yuan L, Zhou Q, Chen S, et al
    Performance evaluation of eight treponemal antibody tests in China.
    Diagn Microbiol Infect Dis. 2022;104:115790.
    PubMed     Abstract available


  7. KUO P, LeCrone K, Chiu M, Realegeno S, et al
    Analysis of the FAST system for expedited identification and antimicrobial susceptibility testing of bloodborne pathogens.
    Diagn Microbiol Infect Dis. 2022;104:115783.
    PubMed     Abstract available


    November 2022
  8. LEROY AG, Robert M, Carpentier M, Bastidon C, et al
    Assessment of a fully automated RPR assay (Mediace RPR) for serological diagnosis and follow-up of syphilis: a retrospective study.
    Diagn Microbiol Infect Dis. 2022;104:115767.
    PubMed     Abstract available


  9. BALLABEN AS, Galetti R, Ferreira JC, Paziani MH, et al
    Different virulence genetic context of multidrug-resistant CTX-M- and KPC-producing Klebsiella pneumoniae isolated from cerebrospinal fluid.
    Diagn Microbiol Infect Dis. 2022;104:115784.
    PubMed     Abstract available


  10. MCCARTY TP, White CM, Meeder J, Moates D, et al
    Analytical performance and potential clinical utility of the GenMark Dx ePlex(R) blood culture identification gram-positive panel.
    Diagn Microbiol Infect Dis. 2022;104:115762.
    PubMed     Abstract available


  11. YOSHIDA S, Tsuyuguchi K, Kobayashi T, Shimatani Y, et al
    Effect of sputum quality on Mycobacterium avium-intracellulare complex lung disease diagnosis and treatment initiation according to disease type.
    Diagn Microbiol Infect Dis. 2022;104:115773.
    PubMed     Abstract available


  12. PIETIKAINEN A, Glader O, Kortela E, Kanerva M, et al
    Borrelia burgdorferi specific serum and cerebrospinal fluid antibodies in Lyme neuroborreliosis.
    Diagn Microbiol Infect Dis. 2022;104:115782.
    PubMed     Abstract available


    October 2022
  13. SASAKI T, Doi Y
    Staphylococcus lugdunensis bacteremia: clinical implications of single set positive blood cultures.
    Diagn Microbiol Infect Dis. 2022;105:115835.
    PubMed     Abstract available


  14. LIM YK, Kweon OJ, Kim HR, Kim TH, et al
    Comparison of simulated candidemia detection during prophylactic antifungal therapy.
    Diagn Microbiol Infect Dis. 2022;104:115768.
    PubMed     Abstract available


  15. PRUSSING C, Southwick K, Snavely E, Kidney A, et al
    Comparative analysis of multiplexed PCR and short- and long-read whole genome sequencing to investigate a large Klebsiella pneumoniae outbreak in New York State.
    Diagn Microbiol Infect Dis. 2022;104:115765.
    PubMed     Abstract available


  16. ZHAO J, Lu B, Zhou Y, Wang S, et al
    Molecular identification and clinical significance of Mycobacterium seoulense strains from patients with nontuberculous mycobacterium infections.
    Diagn Microbiol Infect Dis. 2022;104:115756.
    PubMed     Abstract available


  17. MENTULA S, Paakkanen J, Hyyrylainen HL
    External quality assessment by European mycobacterial laboratories: results of AFB microscopy and identification rounds.
    Diagn Microbiol Infect Dis. 2022;104:115757.
    PubMed     Abstract available


    September 2022
  18. SADER HS, Castanheira M, Duncan LR, Mendes RE, et al
    Update on the in vitro activity of ceftaroline against Staphylococcus aureus from United States (US) medical centers stratified by infection type (2018-2020).
    Diagn Microbiol Infect Dis. 2022;105:115820.
    PubMed     Abstract available


  19. KHRULNOVA S, Fedorova A, Frolova I, Tandilova K, et al
    Distribution of virulence genes and capsule types in Klebsiella pneumoniae among bloodstream isolates from patients with hematological malignancies.
    Diagn Microbiol Infect Dis. 2022;104:115744.
    PubMed     Abstract available


  20. BOYANOVA L, Kandilarov N, Hadzhiyski P, Gergova R, et al
    Increase in amoxicillin resistance in Helicobacter pylori from Bulgarian patients over 15 years.
    Diagn Microbiol Infect Dis. 2022;104:115746.
    PubMed     Abstract available


  21. DURSKI M, Ravel J, Spautz ACPG, Carvalho NS, et al
    Comparison of two microscopic interpretations of vaginal microbiota with molecular profiling.
    Diagn Microbiol Infect Dis. 2022;104:115728.
    PubMed     Abstract available


    August 2022
  22. GO JR, Baddour LM, Lahr BD, Sohail MR, et al
    The skip phenomenon in Staphylococcus aureus bacteremia: clinical implications.
    Diagn Microbiol Infect Dis. 2022;104:115802.
    PubMed     Abstract available


  23. ARONIN SI, Dunne MW, Yu KC, Watts JA, et al
    Increased rates of extended-spectrum beta-lactamase isolates in patients hospitalized with culture-positive urinary Enterobacterales in the United States: 2011 - 2020.
    Diagn Microbiol Infect Dis. 2022;103:115717.
    PubMed     Abstract available


  24. COWMAN K, Rossi J, Gendlina I, Guo Y, et al
    Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients.
    Diagn Microbiol Infect Dis. 2022;103:115721.
    PubMed     Abstract available


    July 2022
  25. LAUPLAND KB, Harris PNA, Stewart AG, Edwards F, et al
    Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections.
    Diagn Microbiol Infect Dis. 2022;104:115772.
    PubMed     Abstract available


  26. DAHAN NASSY S, Azrad M, Abozaid S, Glikman D, et al
    Assessing the impact of a positive Biofire(R) FilmArray(R) Meningitis/Encephalitis Panel result on clinical management and outcomes.
    Diagn Microbiol Infect Dis. 2022;104:115769.
    PubMed     Abstract available


  27. BRIDWELL MR, Bajaj S, Gress TW, Hambuchen MD, et al
    Impact of MRSA polymerase chain reaction (PCR) wound swabs on antibiotic de-escalation in skin and soft tissue infections.
    Diagn Microbiol Infect Dis. 2022;103:115722.
    PubMed     Abstract available


  28. ANNE-GAELLE R, Celia S, Jeanne C, Frederic B, et al
    Performances of the BD MAX CDIFF assay for the detection of toxigenic Clostridioides difficile using Cary-Blair preserved samples.
    Diagn Microbiol Infect Dis. 2022;103:115701.
    PubMed     Abstract available


  29. YOO IY, Shin DP, Heo W, Ha SI, et al
    Comparison of BD MAX Check-Points CPO assay with Cepheid Xpert Carba-R assay for the detection of carbapenemase-producing Enterobacteriaceae directly from rectal swabs.
    Diagn Microbiol Infect Dis. 2022;103:115716.
    PubMed     Abstract available


  30. VAILLANT JJ, Cunningham SA, Patel R
    Antibiotic susceptibility testing of Staphylococcus aureus using the Biolog OmniLog(R) system, a metabolic phenotyping assay.
    Diagn Microbiol Infect Dis. 2022;104:115759.
    PubMed     Abstract available


    June 2022
  31. KOBAYASHI Y, Shibata S, Yagi T
    Molecular epidemiology and antimicrobial susceptibility profiles of Campylobacter jejuni isolated from bloodstream infections and enteritis in Japan.
    Diagn Microbiol Infect Dis. 2022;103:115681.
    PubMed     Abstract available


    May 2022
  32. CLOSE RM, Sutcliffe CG, Galdun P, Reid A, et al
    Point-of-care molecular diagnostics for the detection of group A Streptococcus in non-invasive skin and soft tissue infections: a validation study.
    Diagn Microbiol Infect Dis. 2022;103:115729.
    PubMed     Abstract available


  33. YU HJ, Kim TY, Shim HJ, Yun SA, et al
    Comparison between the STANDARD F S. Pneumoniae Ag FIA and BinaxNOW S. Pneumoniae Antigen Card for Detection of Streptococcus Pneumoniae Urinary Antigen.
    Diagn Microbiol Infect Dis. 2022;104:115725.
    PubMed     Abstract available


  34. YAMADA T, Minami K, Oda K, Suzuki K, et al
    Probability of target attainment of oral antimicrobials for Escherichia coli and Klebsiella pneumoniae based on Monte Carlo simulations.
    Diagn Microbiol Infect Dis. 2022;103:115662.
    PubMed     Abstract available


  35. KHODER M, Rafei R, Osman M, Kassem II, et al
    Emergence of a Neisseria flavescens clinical strain with a high level of third-generation cephalosporins resistance in Lebanon.
    Diagn Microbiol Infect Dis. 2022;103:115660.
    PubMed     Abstract available


  36. ZHU X, Zhao Y, Zhu C, Wang Y, et al
    Rapid detection of cagA-positive Helicobacter pylori based on duplex recombinase aided amplification combined with lateral flow dipstick assay.
    Diagn Microbiol Infect Dis. 2022;103:115661.
    PubMed     Abstract available


  37. PIETIKAINEN A, Backman I, Henningsson AJ, Hytonen J, et al
    Clinical performance and analytical accuracy of a C6 peptide-based point-of-care lateral flow immunoassay in Lyme borreliosis serology.
    Diagn Microbiol Infect Dis. 2022;103:115657.
    PubMed     Abstract available


    April 2022
  38. DIENSTHUBER D, Simnacher U, Peters S, Walther P, et al
    Clearing Chlamydia abortus infection in epithelial cells and primary human macrophages by use of antibiotics and the MDM2-p53-inhibitor nutlin-3.
    Diagn Microbiol Infect Dis. 2022;103:115715.
    PubMed     Abstract available


  39. AONO A, Murase Y, Chikamatsu K, Igarashi Y, et al
    In vitro activity of tedizolid and linezolid against multidrug-resistant Mycobacterium tuberculosis: a comparative study using microdilution broth assay and genomics.
    Diagn Microbiol Infect Dis. 2022;103:115714.
    PubMed     Abstract available


  40. ROSTAMIAN M, Kooti S, Mohammadi B, Salimi Y, et al
    A systematic review and meta-analysis of Listeria monocytogenes isolated from human and non-human sources: the antibiotic susceptibility aspect.
    Diagn Microbiol Infect Dis. 2022;102:115634.
    PubMed     Abstract available


  41. YOSHIMURA M, Tokushige C, Maruyama JI, Kawano Y, et al
    Emerging resistance to beta-lactams in Pantoea ananatis isolated from an immunocompetent patient with bacteremia.
    Diagn Microbiol Infect Dis. 2022;102:115633.
    PubMed     Abstract available


  42. PRINCE HE, Batterman HJ, Realegeno SE, Marlowe EM, et al
    Transience of interference in an immunoassay measuring serum levels of beta-D-glucan.
    Diagn Microbiol Infect Dis. 2022;102:115630.
    PubMed     Abstract available


  43. PFALLER MA, Carvalhaes CG, DeVries S, Huband MD, et al
    Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019.
    Diagn Microbiol Infect Dis. 2022;102:115627.
    PubMed     Abstract available


    March 2022
  44. SAVINOVA T, Bocharova Y, Mayanskiy N, Chebotar I, et al
    Genetic determinants of virulence and antibiotic resistance are common for Pseudomonas aeruginosa ST235 isolates from cystic fibrosis patients from various geographical regions.
    Diagn Microbiol Infect Dis. 2022;102:115596.
    PubMed     Abstract available


    February 2022
  45. BOSCHIERO MN, Duarte A, Palamim CVC, Alvarez AE, et al
    Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing.
    Diagn Microbiol Infect Dis. 2022;102:115576.
    PubMed     Abstract available


  46. SUN Y, Shukla MR, Deutsch J, Cao W, et al
    Evaluation of the effect of extended refrigerated storage of serum and plasma specimens on syphilis serologic test results.
    Diagn Microbiol Infect Dis. 2022;102:115588.
    PubMed     Abstract available


  47. MELENDEZ JH, Chen FE, Wang TH
    Antimicrobial susceptibility testing of Neisseria gonorrhoeae using a phenotypic-molecular assay and lyophilized antimicrobials.
    Diagn Microbiol Infect Dis. 2022;102:115590.
    PubMed     Abstract available


  48. ROSSATO L, Arantes JP, Ribeiro SM, Simionatto S, et al
    Antibacterial activity of gallium nitrate against polymyxin-resistant Klebsiella pneumoniae strains.
    Diagn Microbiol Infect Dis. 2022;102:115569.
    PubMed     Abstract available


    January 2022
  49. BOLKER A, Coe K, Smith J, Stevenson K, et al
    Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients.
    Diagn Microbiol Infect Dis. 2022;102:115558.
    PubMed     Abstract available


  50. SADER HS, Mendes RE, Streit JM, Carvalhaes CG, et al
    Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020).
    Diagn Microbiol Infect Dis. 2022;102:115557.
    PubMed     Abstract available


  51. WORMSER GP
    A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease.
    Diagn Microbiol Infect Dis. 2022;102:115572.
    PubMed     Abstract available


    December 2021
  52. MEEX C, Devey A, Defeche J, Bontems S, et al
    Evaluation of the Revogene(R) GBS DS assay performance for the intrapartum screening of group B streptococcus in comparison with intrapartum culture.
    Diagn Microbiol Infect Dis. 2021;102:115616.
    PubMed     Abstract available


  53. DE BENEDETTO I, Boglione L
    Reply to: impact of Chronic Hepatitis C virus co-infection on outcomes of infective endocarditis in people who inject drugs.
    Diagn Microbiol Infect Dis. 2021;102:115615.
    PubMed    


  54. CHOI H, Hwang M, Chatterjee P, Jinadatha C, et al
    Rare Lelliottia nimipressuralis from a wound infection case report using whole genome sequencing-based bacterial identification.
    Diagn Microbiol Infect Dis. 2021;101:115538.
    PubMed     Abstract available


  55. HU S, Lv Z, Wang Y, Shen J, et al
    Novel Quadruplex PCR for detecting and genotyping mobile colistin resistance genes in human samples.
    Diagn Microbiol Infect Dis. 2021;101:115419.
    PubMed     Abstract available


  56. BUTCHER M, Puiu D, Romagnoli M, Carroll KC, et al
    Rapidly fatal infection with Bacillus cereus/thuringiensis: genome assembly of the responsible pathogen and consideration of possibly contributing toxins.
    Diagn Microbiol Infect Dis. 2021;101:115534.
    PubMed     Abstract available


  57. WOODSON EN, Katz SS, Mosley SS, Danavall DC, et al
    Use of real-time PCR as an alternative to conventional genotyping methods for the laboratory detection of lymphogranuloma venereum (LGV).
    Diagn Microbiol Infect Dis. 2021;101:115532.
    PubMed     Abstract available


  58. BOUSSI LS, Popli T, Feola N, Nog R, et al
    Clinical and microbiological characteristics of patients with bacteremia and normal procalcitonin.
    Diagn Microbiol Infect Dis. 2021;101:115515.
    PubMed     Abstract available


  59. SADEK M, Poirel L, Dominguez Pino M, D'Emidio F, et al
    Evaluation of SuperCAZ/AVI(R) Medium for Screening Ceftazidime-avibactam Resistant Gram-negative Isolates.
    Diagn Microbiol Infect Dis. 2021;101:115475.
    PubMed     Abstract available


  60. SCANGARELLA-OMAN NE, Dixon P, Koeth LM, DiFranco-Fisher J, et al
    Analysis of antimicrobial susceptibility testing methods and variables and in vitro activity of gepotidacin against urogenital Neisseria gonorrhoeae in men.
    Diagn Microbiol Infect Dis. 2021;101:115484.
    PubMed     Abstract available


  61. SENCHYNA F, Tamburini FB, Murugesan K, Watz N, et al
    Comparative genomics of Enterobacter cloacae complex before and after acquired clinical resistance to Ceftazidime-Avibactam.
    Diagn Microbiol Infect Dis. 2021;101:115511.
    PubMed     Abstract available


  62. HOVAN MR, Narayanan N, Cedarbaum V, Bhowmick T, et al
    Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia.
    Diagn Microbiol Infect Dis. 2021;101:115505.
    PubMed     Abstract available


  63. AKAPELWA ML, Kapalamula TF, Ouchi-Aizu Y, Hang'ombe BM, et al
    Evaluation of IS1245 LAMP in Mycobacterium avium and the influence of host-related genetic diversity on its application.
    Diagn Microbiol Infect Dis. 2021;101:115494.
    PubMed     Abstract available


    November 2021
  64. HEIREMAN L, Bruynseels P, Camps K, Geysels D, et al
    Comparison of the QuantiFERON-TB(R) Gold Plus on LIAISON(R) XL and T-SPOT.TB for the diagnosis of latent Mycobacterium tuberculosis infection in a low tuberculosis incidence population.
    Diagn Microbiol Infect Dis. 2021;102:115613.
    PubMed     Abstract available


  65. LOPEZ-PINTOR JM, Martinez-Garcia L, Maruri A, Menendez B, et al
    Quantification of plasmid copy number as surrogate marker of virulence among different invasive and non-invasive genotypes of Chlamydia trachomatis.
    Diagn Microbiol Infect Dis. 2021;102:115610.
    PubMed     Abstract available


  66. MCCREERY R, Nielsen L, Clarey D, Murphy C, et al
    Evaluation of cerebrospinal fluid white blood cell count criteria for use of the BioFire(R) FilmArray(R) Meningitis/Encephalitis Panel in immunocompromised and nonimmunocompromised patients.
    Diagn Microbiol Infect Dis. 2021;102:115605.
    PubMed     Abstract available


  67. JIANG X, Zhu L, Zhan D
    Development of a recombinase polymerase amplification assay for rapid detection of Streptococcus suis type 2 in nasopharyngeal swab samples.
    Diagn Microbiol Infect Dis. 2021;102:115594.
    PubMed     Abstract available


  68. ZAMORA-CINTAS MI, Lopez DJ, Blanco AC, Rodriguez TM, et al
    Coinfections among hospitalized patients with covid-19 in the first pandemic wave.
    Diagn Microbiol Infect Dis. 2021;101:115416.
    PubMed     Abstract available


  69. NOVY E, Goury A, Thivilier C, Guillard T, et al
    Algorithm for rational use of Film Array Pneumonia Panel in bacterial coinfections of critically ill ventilated COVID-19 patients.
    Diagn Microbiol Infect Dis. 2021;101:115507.
    PubMed     Abstract available


  70. RUIZ-BASTIAN M, Falces-Romero I, Ramos-Ramos JC, de Pablos M, et al
    Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: Surfing the first wave.
    Diagn Microbiol Infect Dis. 2021;101:115477.
    PubMed     Abstract available


  71. TIMBROOK TT, Hueth KD, Ginocchio CC
    Identification of bacterial co-detections in COVID-19 critically Ill patients by BioFire(R) FilmArray(R) pneumonia panel: a systematic review and meta-analysis.
    Diagn Microbiol Infect Dis. 2021;101:115476.
    PubMed     Abstract available


  72. UGABAN KB, She RC
    The clinical significance of staphylococcus pettenkoferi: a retrospective review at a tertiary care medical center.
    Diagn Microbiol Infect Dis. 2021;102:115592.
    PubMed     Abstract available


  73. YONETANI S, Hirao C, Ohnishi H
    Background of patients with Aerococcus spp. detected in blood cultures, and drug sensitivity of Aerococcus spp.
    Diagn Microbiol Infect Dis. 2021;101:115506.
    PubMed     Abstract available


  74. DIEZ A, Carrano G, Bregon-Villahoz M, Cuetara MS, et al
    Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients.
    Diagn Microbiol Infect Dis. 2021;101:115509.
    PubMed     Abstract available


  75. RUSSELLO G, Moramarco A, Vizzini L, Farina C, et al
    Diagnostic approach and epidemiology of Microbial Keratitis: findings from an Italian Tertiary Care center.
    Diagn Microbiol Infect Dis. 2021;101:115470.
    PubMed     Abstract available


  76. PFALLER MA, Carvalhaes CG, Messer SA, Rhomberg PR, et al
    In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
    Diagn Microbiol Infect Dis. 2021;101:115473.
    PubMed     Abstract available


  77. VALIATTI TB, Santos FF, Nunes PHS, Cayo R, et al
    Characterization of virulent Klebsiella variicola recovered from inpatients with intestinal and extraintestinal infections between 1987 and 1999.
    Diagn Microbiol Infect Dis. 2021;101:115482.
    PubMed    


  78. PHILLIPS TR, Tabesh M, Fairley CK, Maddaford K, et al
    A comparison of cotton-tipped and nylon flocked swabs for culture of Neisseria gonorrhoeae from oropharyngeal samples.
    Diagn Microbiol Infect Dis. 2021;101:115455.
    PubMed     Abstract available


  79. LIN BB, Pattle N, Kelley P, Jaksic AS, et al
    Multiplex RT-PCR provides improved diagnosis of skin and nail dermatophyte infections compared to microscopy and culture: a laboratory study and review of the literature.
    Diagn Microbiol Infect Dis. 2021;101:115413.
    PubMed     Abstract available


    October 2021
  80. MORRISON AR, Jones MC, Makowski CT, Samuel LP, et al
    Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis.
    Diagn Microbiol Infect Dis. 2021;102:115571.
    PubMed     Abstract available


  81. QUIRINO A, Marascio N, Peronace C, Gallo L, et al
    Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes.
    Diagn Microbiol Infect Dis. 2021;101:115485.
    PubMed     Abstract available


  82. JOSHI P, Shrivastava R, Bhagwat S, Patel M, et al
    Activity of beta-lactam plus beta-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
    Diagn Microbiol Infect Dis. 2021;101:115481.
    PubMed     Abstract available


  83. MALCZYNSKI M, Zhu A, Zembower T, Qi C, et al
    Diagnostic performance of Ion 16S metagenomics kit and Ion reporter metagenomics workflow for bacterial pathogen detection in culture-negative clinical specimens from sterile sources.
    Diagn Microbiol Infect Dis. 2021;101:115451.
    PubMed     Abstract available


  84. JOHNSTON MM, Huang V, Hall ST, Buckley MS, et al
    Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?
    Diagn Microbiol Infect Dis. 2021;101:115442.
    PubMed     Abstract available


  85. GOLDEN AR, Fear T, Baxter M, Adam HJ, et al
    Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018.
    Diagn Microbiol Infect Dis. 2021;101:115447.
    PubMed     Abstract available


  86. PARMELAND L, Bourru T, Kyungu V, Rousseau N, et al
    A rapid and inexpensive protocol to screen for third generation cephalosporin-resistant and non-fermenting Gram-negative rods directly in positive blood cultures.
    Diagn Microbiol Infect Dis. 2021;101:115428.
    PubMed     Abstract available


  87. NOVAL M, Heil EL, Williams P, Johnson JK, et al
    The potential impact of discrepancies between automated susceptibility platforms and other testing metho`dologies for cefazolin in the treatment of Enterobacterales bloodstream infections.
    Diagn Microbiol Infect Dis. 2021;101:115483.
    PubMed     Abstract available


  88. WORMSER GP, Strle F, Shapiro ED, Auwaerter PG, et al
    Comparison of the clinical practice guidelines for Lyme disease from the Infectious Diseases Society of America: 2000, 2006, and 2020.
    Diagn Microbiol Infect Dis. 2021;101:115446.
    PubMed    


  89. CLEMMONS AB, Young HN, Bland CM, Jackson B, et al
    Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia.
    Diagn Microbiol Infect Dis. 2021;101:115444.
    PubMed     Abstract available


    September 2021
  90. HIYAMA Y, Sato T, Takahashi S, Yamamoto S, et al
    Reduction of susceptibility to azoles and 5-fluorocytosine and growth acceleration in Candida albicans in glucosuria.
    Diagn Microbiol Infect Dis. 2021;102:115556.
    PubMed     Abstract available


  91. GARCIA-CABALLERO A, de Dios Caballero J, Maruri A, Serrano-Tomas MI, et al
    Evaluation of different phenotypic methods to detect methicillin resistance in Staphylococcus aureus isolates recovered from cystic fibrosis patients.
    Diagn Microbiol Infect Dis. 2021;102:115559.
    PubMed     Abstract available


  92. XIA XJ, Zhong Y, Sang B, Li QP, et al
    Violet colonies of Talaromyces marneffei produce on CHROMagar candida medium.
    Diagn Microbiol Infect Dis. 2021;101:115533.
    PubMed     Abstract available


  93. KUFEL WD, Mastro KA, Steele JM, Wang D, et al
    Impact of a pharmacist-facilitated, evidence-based bundle initiative on Staphylococcus aureus bacteremia management.
    Diagn Microbiol Infect Dis. 2021;101:115535.
    PubMed     Abstract available


  94. ROSALES-REYES R, Esposito F, Fontana H, Lezana-Fernandez JL, et al
    Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection.
    Diagn Microbiol Infect Dis. 2021;101:115454.
    PubMed     Abstract available


  95. ITO A, Ishida T, Tachibana H, Nakanishi Y, et al
    Predictors and usefulness of targeted therapy for pneumococcal community-acquired pneumonia diagnosed by the urinary antigen test: a prospective, observational cohort study.
    Diagn Microbiol Infect Dis. 2021;101:115457.
    PubMed     Abstract available


  96. VAN DEN MUNCKHOF EHA, van Sitter RL, Lamont RF, le Cessie S, et al
    Developing an algorithm for the diagnosis of abnormal vaginal discharge in a dutch clinical setting: a pilot study.
    Diagn Microbiol Infect Dis. 2021;101:115431.
    PubMed     Abstract available


  97. WORMSER GP
    Documentation of a false positive Lyme disease serologic test in a patient with untreated Babesia microti infection carries implications for accurately determining the frequency of Lyme disease coinfections.
    Diagn Microbiol Infect Dis. 2021;101:115429.
    PubMed     Abstract available


  98. MAHAJAN N, Sood S, Das BK, Kapil A, et al
    Molecular characterization of decreased susceptibility to ceftriaxone and genotyping of Neisseria gonorrheae isolates in New Delhi, India.
    Diagn Microbiol Infect Dis. 2021;101:115423.
    PubMed     Abstract available


  99. TICKLER IA, Shettima SA, Dela Cruz CM, Le VM, et al
    Characterization of carbapenem-resistant gram-negative bacterial isolates from Nigeria by whole genome sequencing.
    Diagn Microbiol Infect Dis. 2021;101:115422.
    PubMed     Abstract available


  100. WALKTY A, Karlowsky JA, Baxter MR, Adam HJ, et al
    In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD study, 2016-2019.
    Diagn Microbiol Infect Dis. 2021;101:115418.
    PubMed     Abstract available


  101. KRISTOF K, Adamkova V, Adler A, Gospodarek-Komkowska E, et al
    In vitro activity of ceftazidime-avibactam and comparators against Enterobacterales and Pseudomonas aeruginosa isolates from Central Europe and Israel, 2014-2017 and 2018.
    Diagn Microbiol Infect Dis. 2021;101:115420.
    PubMed     Abstract available


  102. SONG J, Kim S, Park J, Park Y, et al
    Comparison of two beta-D-glucan assays for detecting invasive fungal diseases in immunocompromised patients.
    Diagn Microbiol Infect Dis. 2021;101:115415.
    PubMed     Abstract available


    August 2021
  103. ZHANG CY, Zhang HH, Zhao SL, Wu HY, et al
    Clinical value of alkaline phosphatase on the surface membrane of neutrophils for prediction of bacteremia in patients with systemic inflammatory response syndrome.
    Diagn Microbiol Infect Dis. 2021;100:114105.
    PubMed     Abstract available


  104. BIBBOLINO G, Di Lella FM, Oliva A, Lichtner M, et al
    Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017-2019.
    Diagn Microbiol Infect Dis. 2021;100:115399.
    PubMed     Abstract available


  105. CLAY TB, Orwig KW, Stevens RA, Davis EP, et al
    Correlation of MRSA polymerase chain reaction (PCR) wound swab testing and wound cultures in skin and soft tissue infections.
    Diagn Microbiol Infect Dis. 2021;100:115389.
    PubMed     Abstract available


    July 2021
  106. SAPOZHNIKOV J, Huang A, Zeeck K, Gibble A, et al
    Comparison of outcomes in urinary tract infections caused by AmpC-harboring organisms treated with AmpC stable versus AmpC susceptible agents.
    Diagn Microbiol Infect Dis. 2021;101:115472.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: